Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents
Key Points. Number of NAs used prior to alloHCT and NA immediately preceding alloHCT do not impact survival outcomes.Hematopoietic cell transplantation-specifi
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 August 2020
|
| In: |
Blood advances
Year: 2020, Jahrgang: 4, Heft: 16, Pages: 3977-3989 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2020001956 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2020001956 Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/bloodadvances/article/4/16/3977/463451/Allogeneic-stem-cell-transplantation-for-chronic |
| Verfasserangaben: | Lindsey E. Roeker, Peter Dreger, Jennifer R. Brown, Oscar B. Lahoud, Toby A. Eyre, Danielle M. Brander, Alan Skarbnik, Catherine C. Coombs, Haesook T. Kim, Matthew Davids, Steven T. Manchini, Gemlyn George, Nirav Shah, Timothy J. Voorhees, Kim H. Orchard, Harriet S. Walter, Arvind K. Arumainathan, Andrea Sitlinger, Jae H. Park, Mark B. Geyer, Andrew D. Zelenetz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, and Anthony R. Mato |
| Zusammenfassung: | Key Points. Number of NAs used prior to alloHCT and NA immediately preceding alloHCT do not impact survival outcomes.Hematopoietic cell transplantation-specifi |
|---|---|
| Beschreibung: | Gesehen am 29.09.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2020001956 |